BioCentury
ARTICLE | Company News

Ivax, Ferrer deal

November 1, 2004 8:00 AM UTC

IVAX and Grupo Ferrer partnered to develop citicoline, an oral neuroprotective therapy to treat stroke. Under the deal, IVAX will be responsible for regulatory approval in the U.S. The compound is mar...